Mengyao Wu
- Molecular Biology
- Oncology top 10%
- Cancer Research top 10%
- Immunology
- Epidemiology
- Topics
- Inflammatory Biomarkers in Disease Prognosis (10 papers)MicroRNA in disease regulation (6 papers)Pancreatic and Hepatic Oncology Research (5 papers)
- Cited by
- Cancer ResearchOncologyImmunology
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Mengyao Wu
64 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 100
- Molecular Biology 519
- Oncology 365
- Cancer Research 262
- Immunology 211
- Epidemiology 149
Countries citing papers authored by Mengyao Wu
This map shows the geographic impact of Mengyao Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengyao Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengyao Wu more than expected).
Fields of papers citing papers by Mengyao Wu
This network shows the impact of papers produced by Mengyao Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengyao Wu. The network helps show where Mengyao Wu may publish in the future.
Co-authorship network of co-authors of Mengyao Wu
This figure shows the co-authorship network connecting the top 25 collaborators of Mengyao Wu. A scholar is included among the top collaborators of Mengyao Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengyao Wu. Mengyao Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 15 | |
| 5 | 1 | |
| 6 | 10 | |
| 7 | 4 | |
| 8 | 0 | |
| 9 | 5 | |
| 10 | 5 | |
| 11 | 32 | |
| 12 | 7 | |
| 13 | 26 | |
| 14 | 5 | |
| 15 | 1 | |
| 16 | 28 | |
| 17 | 65 | |
| 18 | 15 | |
| 19 | 35 | |
| 20 | 15 |
About Mengyao Wu
Mengyao Wu is a scholar working on Cancer Research, Pharmacology and Immunology, having authored 70 papers that have together received 1.1k indexed citations. Recurring topics across this work include Inflammatory Biomarkers in Disease Prognosis (10 papers), MicroRNA in disease regulation (6 papers) and Pancreatic and Hepatic Oncology Research (5 papers). The work is most often cited by research in Cancer Research (262 citations), Oncology (365 citations) and Immunology (211 citations). Mengyao Wu has collaborated with scholars based in China, United States and France. Frequent co-authors include Fei‐Ran Gong, Mengdan Xu, Meng Shen, Weiming Duan, Min Tao, Kai Chen, Min Tao, Qiaoming Zhi, Liu‐Mei Shou and Min Tao. Their work appears in journals such as Journal of Biological Chemistry, ACS Nano and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.